Skip to main content

Table 1 Main characteristics of all studies included in the meta-analysis

From: Prognostic significance of galectin-1 expression in patients with cancer: a meta-analysis

Study

Country

Cancer

Case number

Median age (year, range)

M/F

Stage

Gal-1 (±) NO.

Cut-off

Multivariate analysis

HR and 95% CI

Wu [5]

Japan

CCA

78

NA

50/28

TNM I–IV

(45/33)

IRS ≥ 3

No

SC

Chen [6]

China

gastric

214

Mean 64.5

129/85

TNM I–IV

(138/76)

IRS ≥ 2

No

SC

Noda [9]

Japan

GSCC

80

Mean 63.8

39/41

TNM I–IV

(22/58)

IHC > 50%

No

SC

Chong [8]

China

Gastric

111

NA

NA

TNM I–IV

(61/50)

IHC > 20%

No

SC

Zhang [10]

China

HCC

209

NA

179/30

TNM I–IV

(128/81)

IHC > 20%

No

SC

Huang [13]

Tainan

RCC

45

NA

31/14

TNM I–IV

(25/20)

H-score > median

No

SC

Le [14]

USA

HNSCC

101

Median 58

84/17

TNM I–IV

(56/44)

IRS ≥ 3

No

SC

Schulz [15]

Germany

Ovarian

150

Median 62 (31–88)

0/150

FIGO I–IV

(102/48)

IRS > 1

No

SC

Chen [7]

China

Gastric

108

NA

61/47

TNM I–IV

(68/40)

IRS ≥ 2

Yes

Report

You [11]

China

HCC

162

NA

127/35

TNM I–IV

(105/57)

IRS ≥ 2

Yes

Report

Wu [12]

China

HCC

386

NA

341/45

TNM I–IV

(189/197)

NA

Yes

Report

Kamper [19]

Denmark

cHL

143

35

78/80

Ann Arbor I–IV

(35/108)

NA

No

Report

Ye [20]

China

LSCC

187

Mean 52.4

179/8

TNM I–IV

(102/85)

NA

No

SC

Szoke [17]

Hungary

NSCLC

94

Mean 58.8

84/10

TNM I–III

(40/54)

NA

No

SC

Carlini [18]

Argentina

NSCLC

103

Median 64 (45–85)

69/34

TNM I–III

(53/47)

IRS > 1

No

SC

Van Woensel [21]

Belgium

GBM

349

NA

NA

NA

(174/175)

Median gene expression

No

Report

Chou [22]

China

GBM

45

NA

27/18

NA

(34/11)

IHC > 35%

No

Report

Chen [16]

China

EOC

109

NA

0/109

FIGO

(91/18)

IRS ≥ 3

Yes

Report

  1. CCA cholangiocarcinoma, GSCC gingival squamous cell carcinoma, HCC hepatocellular carcinoma, RCC renal cell carcinoma, HNSCC head and neck squamous cell carcinomas, cHL classic Hodgkin lymphoma, LSCC laryngeal squamous cell carcinomas, NSCLC non-small cell lung cancer, GBM glioblastoma multiforme, EOC epithelial ovarian cancer, NA not available, SC survival curve, IRS immunoreactivity score, IHC immunohistochemistry